XL-protein Signs Licensing Agreement with MSD Animal Health to Develop Biopharmaceuticals using its PASylation® Technology

FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany,…

XL-protein and YEDA sign business collaboration agreement to commercialize PASylated interferon superagonist

FREISING, GERMANY & REHOVOT, ISRAEL, October 21, 2014 – Yeda…